Onco-D-clare

Onco-D-clare is a cancer screening test designed to identify cancer even before the symptom’s onset. With the ease of a simple blood draw, you can now detect cancer long before any symptoms emerge. Onco-D-clare opens an early door to personalized health insights.

How does Onco-D-clare work?

• Onco-D-clare is based on the synergy of molecular biology with machine learning algorithms. Peripheral blood mononuclear cells are isolated from blood samples, and gene expression analysis is performed on more than 90 genes. The expression profile is then used to classify the sample as cancerous or healthy.

Why choose the Onco-D-clare test?

• The Onco-D-clare test has shown remarkable reliability of results. It has been clinically validated with an approximate accuracy of 93%, ensuring that its insights are rooted in precision and scientific rigor.
• The Onco-D-clare test empowers you with knowledge by offering a nuanced understanding of your cancer risk and the means to chart a proactive course toward a healthier future.
• Onco-D-clare plays a crucial role in cancer care and improving patient outcomes.